FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033507907> ?p ?o ?g. }

• W3033507907 endingPage "658" @default.
• W3033507907 startingPage "646" @default.
• W3033507907 abstract "Germline variations may contribute to lung cancer susceptibility besides environmental factors. The influence of germline mutations on lung cancer susceptibility and their correlation with somatic mutations has not been systematically investigated.In this study, germline mutations from 1,026 non-small cell lung cancer (NSCLC) patients were analyzed with a 58-gene next-generation sequencing (NGS) panel containing known hereditary cancer-related genes, and were categorized based on American College of Medical Genetics and Genomics (ACMG) guidelines in pathogenicity, and the corresponding somatic mutations were analyzed using a 605-gene NGS panel containing known cancer-related genes.Plausible genetic susceptibility was found in 4.7% of lung cancer patients, in which 14 patients with pathogenic mutations (P group) and 34 patients with likely-pathogenic mutations (LP group) were identified. The ratio of the first degree relatives with lung cancer history of the P groups was significantly higher than the Non-P group (P=0.009). The ratio of lung cancer patients with history of other cancers was higher in P (P=0.0007) or LP (P=0.017) group than the Non-P group. Pathogenic mutations fell most commonly in BRCA2, followed by CHEK2 and ATM. Likely-pathogenic mutations fell most commonly in NTRK1 and EXT2, followed by BRIP1 and PALB2. These genes are involved in DNA repair, cell cycle regulation and tumor suppression. By comparing the germline mutation frequency from this study with that from the whole population or East Asian population (gnomAD database), we found that the overall odds ratio (OR) for P or LP group was 17.93 and 15.86, respectively, when compared with the whole population, and was 2.88 and 3.80, respectively, when compared with the East Asian population, suggesting the germline mutations of the P and LP groups were risk factors for lung cancer. Somatic mutation analysis revealed no significant difference in tumor mutation burden (TMB) among the groups, although a trend of lower TMB in the pathogenic group was found. The SNV/INDEL mutation frequency of TP53 in the P group was significantly lower than the other two groups, and the copy number variation (CNV) mutation frequency of PIK3CA and MET was significantly higher than the Non-P group. Pathway enrichment analysis found no significant difference in aberrant pathways among the three groups.A proportion of 4.7% of patients carrying germline variants may be potentially linked to increased susceptibility to lung cancer. Patients with pathogenic germline mutations exhibited stronger family history and higher lung cancer risk." @default.
• W3033507907 created "2020-06-12" @default.
• W3033507907 creator A5002901852 @default.
• W3033507907 creator A5003673833 @default.
• W3033507907 creator A5010427328 @default.
• W3033507907 creator A5018489232 @default.
• W3033507907 creator A5019056174 @default.
• W3033507907 creator A5023632317 @default.
• W3033507907 creator A5024817892 @default.
• W3033507907 creator A5037446400 @default.
• W3033507907 creator A5042680484 @default.
• W3033507907 creator A5045437842 @default.
• W3033507907 creator A5048903694 @default.
• W3033507907 creator A5051601236 @default.
• W3033507907 creator A5056120792 @default.
• W3033507907 creator A5062163968 @default.
• W3033507907 creator A5064260340 @default.
• W3033507907 creator A5066824297 @default.
• W3033507907 creator A5078190129 @default.
• W3033507907 creator A5081268438 @default.
• W3033507907 creator A5089137375 @default.
• W3033507907 creator A5089360026 @default.
• W3033507907 creator A5090253931 @default.
• W3033507907 date "2020-06-01" @default.
• W3033507907 modified "2023-10-15" @default.
• W3033507907 title "The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility" @default.
• W3033507907 cites W1964955321 @default.
• W3033507907 cites W1999922074 @default.
• W3033507907 cites W2051978340 @default.
• W3033507907 cites W2056480599 @default.
• W3033507907 cites W2072881647 @default.
• W3033507907 cites W2096775817 @default.
• W3033507907 cites W2126423964 @default.
• W3033507907 cites W2139587371 @default.
• W3033507907 cites W2152416392 @default.
• W3033507907 cites W2491081100 @default.
• W3033507907 cites W2746878489 @default.
• W3033507907 cites W2759766687 @default.
• W3033507907 cites W2761095060 @default.
• W3033507907 cites W2765722115 @default.
• W3033507907 cites W2807537027 @default.
• W3033507907 cites W2809219312 @default.
• W3033507907 cites W2809721683 @default.
• W3033507907 cites W2890601979 @default.
• W3033507907 cites W2896098340 @default.
• W3033507907 cites W2898234690 @default.
• W3033507907 cites W2910591458 @default.
• W3033507907 doi "https://doi.org/10.21037/tlcr-19-403" @default.
• W3033507907 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7354149" @default.
• W3033507907 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32676327" @default.
• W3033507907 hasPublicationYear "2020" @default.
• W3033507907 type Work @default.
• W3033507907 sameAs 3033507907 @default.
• W3033507907 citedByCount "26" @default.
• W3033507907 countsByYear W30335079072021 @default.
• W3033507907 countsByYear W30335079072022 @default.
• W3033507907 countsByYear W30335079072023 @default.
• W3033507907 crossrefType "journal-article" @default.
• W3033507907 hasAuthorship W3033507907A5002901852 @default.
• W3033507907 hasAuthorship W3033507907A5003673833 @default.
• W3033507907 hasAuthorship W3033507907A5010427328 @default.
• W3033507907 hasAuthorship W3033507907A5018489232 @default.
• W3033507907 hasAuthorship W3033507907A5019056174 @default.
• W3033507907 hasAuthorship W3033507907A5023632317 @default.
• W3033507907 hasAuthorship W3033507907A5024817892 @default.
• W3033507907 hasAuthorship W3033507907A5037446400 @default.
• W3033507907 hasAuthorship W3033507907A5042680484 @default.
• W3033507907 hasAuthorship W3033507907A5045437842 @default.
• W3033507907 hasAuthorship W3033507907A5048903694 @default.
• W3033507907 hasAuthorship W3033507907A5051601236 @default.
• W3033507907 hasAuthorship W3033507907A5056120792 @default.
• W3033507907 hasAuthorship W3033507907A5062163968 @default.
• W3033507907 hasAuthorship W3033507907A5064260340 @default.
• W3033507907 hasAuthorship W3033507907A5066824297 @default.
• W3033507907 hasAuthorship W3033507907A5078190129 @default.
• W3033507907 hasAuthorship W3033507907A5081268438 @default.
• W3033507907 hasAuthorship W3033507907A5089137375 @default.
• W3033507907 hasAuthorship W3033507907A5089360026 @default.
• W3033507907 hasAuthorship W3033507907A5090253931 @default.
• W3033507907 hasBestOaLocation W30335079071 @default.
• W3033507907 hasConcept C104317684 @default.
• W3033507907 hasConcept C109825262 @default.
• W3033507907 hasConcept C121608353 @default.
• W3033507907 hasConcept C13514818 @default.
• W3033507907 hasConcept C135763542 @default.
• W3033507907 hasConcept C143998085 @default.
• W3033507907 hasConcept C153209595 @default.
• W3033507907 hasConcept C2776071976 @default.
• W3033507907 hasConcept C2776256026 @default.
• W3033507907 hasConcept C2778144015 @default.
• W3033507907 hasConcept C2779372377 @default.
• W3033507907 hasConcept C2908647359 @default.
• W3033507907 hasConcept C501734568 @default.
• W3033507907 hasConcept C502942594 @default.
• W3033507907 hasConcept C54355233 @default.
• W3033507907 hasConcept C555283112 @default.
• W3033507907 hasConcept C71924100 @default.
• W3033507907 hasConcept C86803240 @default.

• next